In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization